Biomea Fusion, Inc. (BMEA)
2.03
+0.12
(+6.28%)
USD |
NASDAQ |
Sep 04, 16:00
2.03
0.00 (0.00%)
After-Hours: 20:00
Biomea Fusion Market Cap : 147.14M for Sept. 4, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 04, 2026 | 147.14M |
| September 03, 2026 | 138.44M |
| September 02, 2026 | 140.26M |
| September 01, 2026 | 130.47M |
| August 31, 2026 | 121.77M |
| August 28, 2026 | 125.40M |
| August 27, 2026 | 121.77M |
| August 26, 2026 | 123.95M |
| August 25, 2026 | 125.40M |
| August 24, 2026 | 115.25M |
| August 21, 2026 | 99.30M |
| August 20, 2026 | 98.58M |
| August 19, 2026 | 100.75M |
| August 18, 2026 | 97.85M |
| August 17, 2026 | 97.85M |
| August 14, 2026 | 95.68M |
| August 13, 2026 | 92.78M |
| August 12, 2026 | 92.78M |
| August 11, 2026 | 93.50M |
| August 10, 2026 | 92.05M |
| August 07, 2026 | 91.33M |
| August 06, 2026 | 90.60M |
| August 05, 2026 | 91.33M |
| August 04, 2026 | 89.16M |
| August 03, 2026 | 86.98M |
| Date | Value |
|---|---|
| July 31, 2026 | 84.59M |
| July 30, 2026 | 88.21M |
| July 29, 2026 | 88.21M |
| July 28, 2026 | 90.37M |
| July 27, 2026 | 91.10M |
| July 24, 2026 | 90.37M |
| July 23, 2026 | 91.10M |
| July 22, 2026 | 93.27M |
| July 21, 2026 | 96.16M |
| July 20, 2026 | 94.71M |
| July 17, 2026 | 92.54M |
| July 16, 2026 | 91.10M |
| July 15, 2026 | 93.27M |
| July 14, 2026 | 93.27M |
| July 13, 2026 | 96.16M |
| July 10, 2026 | 95.44M |
| July 09, 2026 | 94.71M |
| July 08, 2026 | 93.99M |
| July 07, 2026 | 101.22M |
| July 06, 2026 | 99.77M |
| July 02, 2026 | 101.94M |
| July 01, 2026 | 98.33M |
| June 30, 2026 | 106.28M |
| June 29, 2026 | 100.50M |
| June 26, 2026 | 95.44M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| REGENXBIO, Inc. | 484.23M |
| ACADIA Pharmaceuticals, Inc. | 4.823B |
| Alnylam Pharmaceuticals, Inc. | 35.59B |
| Anika Therapeutics, Inc. | 278.50M |
| Savara, Inc. | 1.103B |
Market Cap Related Metrics
| Price to Book Value | 12.12 |
| Price | 2.03 |
| Earnings Yield | -24.49% |